كلية الطب البشرىA) Basic Information:
Allocated marks : 1000 marks
Course duration : 24 months of teaching
Teaching hours : 16.25 hours / month = 292.5 total teaching hours
Teaching hours: lectures: 90hrs practical:202.5hrs
B) Professional Information:
1- Overall Aim of the Course:
- To develop high level of knowledge and understanding of the etiology; the pathogenesis; and the clinical, laboratory and pathologic manifestations of the respiratory diseases.
- To interpret properly, information from laboratory and radiology studies that relate to the patients’ conditions,
- To seek consultation from other physicians and health professionals when indicated.
- To communicate with patients and patients’ families about all of their concerns regarding the patients’ health and well-being
- To apply the principles of evidence-based medicine and cost effectiveness in making decisions about the utilization of limited medical resources
- To have the positional of self learning and research
2- Intended Learning Outcomes ( ILOs):
a- Knowledge and understanding:
By the end of the course, postgraduate should be able to:
2.a.1 Demonstrate a thorough knowledge of the etiology, pathogenesis and clinical features.
2.a.2 Recognize complications, principles of prevention and management of all chest diseases and disorders
2.a.3 Confirm diagnosis in term of anatomical, pathological and functional diagnosis,
2.a.4 Differentiate between chest diseases to make a list of priorities
2.a.5 Express the management priorities for different chest emergencies the relative risks , benefits of outcomes and treatment options of common clinical problems.
b- Intellectual skills:
By the end of the course, postgraduate should be able to:
2.b.1 Analyze clinical date and investigations to construct a differential diagnosis on priority bases
2.b.2 Plan investigations appropriately and according to resources on priority bases
2.b.3 Construct appropriate treatment plan incorporating his knowledge, best available evidence and cost – benefits
2.b.4 Point out the indications of referring patients to higher levels of experience or another specialization
2.b.5 evaluate critically the medical literature
2.b.6 Interpret lung function tests and ABGs
c- Professional and practical skills:
By the end of the course, postgraduate should be able to:
2.c.1 Perform PFT to judge fallacies in the test
2.c.2 Perform pleural aspiration without complications
2.c.3 Insert of intercostal tubes and its care
2.c.4 Do skin tests as tuberculin and allergy skin tests and to interpret with results
2.c.5 Diagnose urgent life threatening conditions and institute proper management.
2.c.6 Perform safely immediate life support
2.c.7 Construct methods of sterilization and universal precautions for the invasive techniques.
d- General and transferable skills:
By the end of the course, postgraduate s should be able to:
2.d.1 Present patient’s data in an organized and informative manner.
2.d.2 Communicate effectively with patients and their families using appropriate communication skills.
Communicate and interact effectively with other people and in a small group
2.d.3 Demonstrate appropriate professional attitudes and behaviors in different practice situations
2.d.4 Work as part of a team, recognizing the strengths, weaknesses, needs and sensitivities of others
2.d.5 Establish professional relationships with patients, their families (when appropriate) and community that are characterized by understanding, trust, respect, empathy and confidentiality.
2.d.6 Deliver information to the patient and family (as appropriate) in a human manner, and easily understood, with encourages discussion to promotes the patient’s participation in decision-making.
3- Course contents:
|
subject
|
Lectures (hrs)
|
Tutorial/Small group discussion (hrs)
|
Practical (hrs)
|
Total (hrs)
|
% of total
|
|
Development and structure |
2 |
xxx |
xxx |
2 |
0.7% |
|
Functions of the lung |
2 |
xxx |
xxx |
2 |
0.7% |
|
Acid–base status |
2 |
xxx |
2 |
4 |
1.4 % |
|
Lung mechanics and control of breathing |
2 |
xxx |
2 |
4 |
1.4 % |
|
Lung defences and immunology |
2 |
xxx |
xxx |
2 |
0.7% |
|
Genetics of lung disease |
2 |
xxx |
xxx |
2 |
0.7% |
|
Clinical aspects |
xxx |
xxx |
17 |
17 |
5.8% |
|
Intercostal intubation |
2 |
xxx |
8 |
10 |
3.45 |
|
Fiberoptic bronchoscope and thoracoscope |
2 |
xxx |
4 |
6 |
2.1% |
|
Pft |
2 |
4 |
4 |
10 |
3.4% |
|
Oxygen therapy and nebulizers |
2 |
2 |
6 |
10 |
3.4% |
|
Diagnostic imaging |
2 |
4 |
6 |
12 |
4.1% |
|
SMOKING and air pollution |
2 |
2 |
xxx |
4 |
1.4 % |
|
Acute upper respiratory tract infection |
2 |
xxx |
xxx |
2 |
0.7% |
|
Pneumonia |
2 |
xxx |
4 |
6 |
% 2 |
|
Lung abscess |
2 |
xxx |
xxx |
2 |
0.7% |
|
Tuberculosis |
6 |
2 |
120 |
128 |
43.8% |
|
Fungal and parasitic diseases |
2 |
xxx |
xxx |
2 |
0.7% |
|
Chronic bronchitis and emphysema |
2 |
4 |
4 |
10 |
3.4% |
|
Respiratory failure |
2 |
xxx |
2 |
4 |
1.4 % |
|
Pulmonary embolism |
2 |
xxx |
xxx |
2 |
0.7% |
|
Bronchiectasis |
2 |
xxx |
2 |
4 |
1.4 % |
|
Cystic fibrosis |
2 |
xxx |
xxx |
2 |
0.7% |
|
Interstitial lung diseases |
2 |
xxx |
xxx |
2 |
0.7% |
|
Asthma |
2 |
4 |
xxx |
6 |
2.1% |
|
Lung cancer |
6 |
4 |
2 |
12 |
4.1% |
|
Diseases of the pleura |
4 |
xxx |
2 |
6 |
% 2 |
|
Chest wall and neuromuscular disorders |
2 |
xxx |
xxx |
2 |
0.7% |
|
Diseases of the diaphragm |
2 |
xxx |
xxx |
2 |
0.7% |
|
Sleep related disorders |
2 |
xxx |
1.5 |
3.5 |
1.2 % |
|
Diseases of the mediastinum |
2 |
xxx |
xxx |
2 |
0.7% |
|
Pulmonary manifestations of systemic disease |
2 |
xxx |
2 |
0.7% |
|
|
Occupational lung diseases, |
2 |
xxx |
2 |
4 |
1.4 % |
|
Lung transplantation |
2 |
xxx |
xxx |
2 |
0.7% |
|
Terminal care in respiratory diseases |
2 |
xxx |
xxx |
2 |
0.7% |
|
Nanotecnology in chest diseases |
2 |
xxx |
xxx |
2 |
0.7% |